NCT06377839

Brief Summary

Pain is the most common complication following surgical removal of an impacted mandibular third molar. Several risk factors may increase the intensity and duration of pain following removal of mandibular third molars. Acute postoperative pain can transcript into postoperative chronic pain without an explainable reason or a specific risk factor. The use of advanced platelet-rich fibrin in the extraction socket following surgical removal of mandibular third molar have diminished the intensity and duration of acute postoperative pain and facilitated improved wound healing. The objective of the present study is therefore to identified specific risk factors and predictors for developing postoperative chronic pain following surgical removal of mandibular third molars with or without advanced platelet-rich fibrin applied in the extraction socket using epigenetic modulation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 9, 2024

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 17, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 22, 2024

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

April 22, 2024

Status Verified

April 1, 2024

Enrollment Period

3 months

First QC Date

April 9, 2024

Last Update Submit

April 17, 2024

Conditions

Keywords

Pain, surgery, quality of life,

Outcome Measures

Primary Outcomes (1)

  • Assessment of postoperative pain by using Visual Analoque scale

    Measurements of pain using Visual Analogue Scale (0 is no pain and 100 is the worst pain), so lower score is a better outcome

    Postoperative (15 days)

Secondary Outcomes (1)

  • Assessment of quality of life

    Pre- and postoperative (1-year)

Study Arms (2)

With advanced platelet-rich fibrin in the ekstraction socket

ACTIVE COMPARATOR

Right or left side of the mandible

Biological: Advanced platelet-rich fibrin in the ekstraction socket

Without advanced platelet-rich fibrin in the ekstraction socket

PLACEBO COMPARATOR

Right or left side of the mandible

Biological: Advanced platelet-rich fibrin in the ekstraction socket

Interventions

Advanced platelet-rich fibrin is a centrifuged fibrin matrix composed of concentrated growth factors, platelet cytokines, and blood cells, which possesses the ability to stimulate wound healing and tissue regeneration. Advanced platelet-rich fibrin is manufacturing from a blood sample.

With advanced platelet-rich fibrin in the ekstraction socketWithout advanced platelet-rich fibrin in the ekstraction socket

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years.
  • Presence of a semi- or fully impacted mandibular third molar.
  • Indication for surgical removal of mandibular third molar.

You may not qualify if:

  • Patients suffering from chronic pain syndrome.
  • Patients in need of daily analgetic.
  • Pregnancy.
  • Psychiatric problems or unrealistic expectations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Oral and Maxillofacial surgery, Aalborg University Hospital

Aalborg, North Denmark, 9000, Denmark

RECRUITING

MeSH Terms

Conditions

Somatoform DisordersPain

Condition Hierarchy (Ancestors)

Mental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, consultant surgeon, DDS, PhD

Study Record Dates

First Submitted

April 9, 2024

First Posted

April 22, 2024

Study Start

January 10, 2024

Primary Completion

April 17, 2024

Study Completion

December 1, 2025

Last Updated

April 22, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations